Ligand Pharmaceuticals Incorporated (LGND)
Number of days of payables
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Payables turnover | — | — | — | — | — | |
Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided indicates that the number of days of payables for Ligand Pharmaceuticals Incorporated is not available for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. As such, without this specific financial metric, it is challenging to assess the company's efficiency in paying its suppliers and managing its working capital through the analysis of days of payables. It is essential for stakeholders to seek further information or a complete set of financial statements to gain a clearer understanding of Ligand Pharmaceuticals' payables management.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
Ligand Pharmaceuticals Incorporated
LGND
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
43.80
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.38
Catalyst Pharmaceuticals Inc
CPRX
—